These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27620302)

  • 41. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caspase-1 levels in biological fluids from patients with multiple sclerosis and from patients with other neurological and non-neurological diseases.
    Franciotta D; Martino G; Zardini E; Furlan R; Bergamaschi R; Gironi M; Bergami A; Angelini G; De Benedetti F; Pignatti P; Moscato G; Cosi V
    Eur Cytokine Netw; 2002; 13(1):99-103. PubMed ID: 11956027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.
    Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH
    Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients.
    Hirotani M; Maita C; Niino M; Iguchi-Ariga S; Hamada S; Ariga H; Sasaki H
    Mult Scler; 2008 Sep; 14(8):1056-60. PubMed ID: 18632777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis.
    Bogunia-Kubik K; Świerkot J; Malak A; Wysoczańska B; Nowak B; Białowąs K; Gębura K; Korman L; Wiland P
    Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):215-21. PubMed ID: 25387578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Possible mechanisms of peripheral elevated CD8+ IL-17+ T cells in rheumatoid arthritis].
    Wang T; Zhao Y; Liu X; Liu X; Li R; Ren LM; Ye H; Li ZG
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1885-8. PubMed ID: 19953909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients.
    Caruso D; Melis M; Fenu G; Giatti S; Romano S; Grimoldi M; Crippa D; Marrosu MG; Cavaletti G; Melcangi RC
    J Neurochem; 2014 Aug; 130(4):591-7. PubMed ID: 24766130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis.
    Hazlett J; Stamp LK; Merriman T; Highton J; Hessian PA
    Genes Immun; 2012 Apr; 13(3):282-7. PubMed ID: 22130325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine patterns after therapy with Avonex®, Rebif®, Betaferon® and CinnoVex™ in relapsing-remitting multiple sclerosis in Iranian patients.
    Arababadi MK; Mosavi R; Khorramdelazad H; Yaghini N; Zarandi ER; Araste M; Pourali R; Nekhei Z; Kennedy D
    Biomark Med; 2010 Oct; 4(5):755-9. PubMed ID: 20945990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.
    Zrioual S; Ecochard R; Tournadre A; Lenief V; Cazalis MA; Miossec P
    J Immunol; 2009 Mar; 182(5):3112-20. PubMed ID: 19234208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
    Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
    Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated interleukin 2 levels in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Tomioka R; Hamaguchi K; Ohno R; Hosokawa T; Kaneko A; Tsuji T; Kurihara K
    Ann N Y Acad Sci; 1992 Apr; 650():347-50. PubMed ID: 1605493
    [No Abstract]   [Full Text] [Related]  

  • 57. Multiple sclerosis: search for a serologic inhibitor.
    Ryberg B
    Acta Neurol Scand; 1980 Sep; 62(3):193-6. PubMed ID: 7211171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF and serum interferon in multiple sclerosis: longitudinal study.
    Salonen R
    Neurology; 1983 Dec; 33(12):1604-6. PubMed ID: 6196687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significantly higher levels of soluble interleukin 2 in patients with relapsing-remitting multiple sclerosis compared with healthy subjects.
    Capra R; Mattioli F; Marcianò N; Vignolo LA; Bettinzioli M; Airò P; Cattaneo R
    Arch Neurol; 1990 Mar; 47(3):254. PubMed ID: 2310308
    [No Abstract]   [Full Text] [Related]  

  • 60. Interleukin-2 receptor levels indicating relapse in multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Lancet; 1989 Mar; 1(8637):559-60. PubMed ID: 2564093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.